Replies to post #8229 on Tenax Therapeutics Inc (TENX)

[crudeoil24]

Levosimendan approved safe and effective for acute decompensated heart failure in 60+ countries since 2000
Intravenous levosimendan first treatment to show efficacy in PH-HFpEF in the Tenax Phase 2 trial
FDA agreement to use oral levosimendan formulation in Phase 3 development program
Discovery of levosimendan’s novel mechanism of action and treatment target makes it uniquely effective for HFpEF patients